These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37831150)
1. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey. Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150 [TBL] [Abstract][Full Text] [Related]
2. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review. Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979 [TBL] [Abstract][Full Text] [Related]
3. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related]
4. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment. Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550 [TBL] [Abstract][Full Text] [Related]
5. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study. Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151 [TBL] [Abstract][Full Text] [Related]
6. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement? Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789 [TBL] [Abstract][Full Text] [Related]
7. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin. Marion MH; Humberstone M; Grunewald R; Wimalaratna S Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927 [TBL] [Abstract][Full Text] [Related]
8. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin. Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S; J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and cervical dystonia: a seven-year follow-up. Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of focal dystonia with botulinum toxin A]. Sojer M; Wissel J; Müller J; Poewe W Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045 [TBL] [Abstract][Full Text] [Related]
11. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections. Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031 [TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia. Comella C; Ferreira JJ; Pain E; Azoulai M; Om S J Neurol; 2021 Mar; 268(3):903-912. PubMed ID: 32939574 [TBL] [Abstract][Full Text] [Related]
13. "Pseudo"-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study. Hefter H; Rosenthal D; Samadzadeh S Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888649 [TBL] [Abstract][Full Text] [Related]
14. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia. Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195 [TBL] [Abstract][Full Text] [Related]
15. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia. Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. Kessler KR; Skutta M; Benecke R J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694 [TBL] [Abstract][Full Text] [Related]
17. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients. Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type B for cervical dystonia. Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941 [TBL] [Abstract][Full Text] [Related]
19. Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia. Hilker R; Schischniaschvili M; Ghaemi M; Jacobs A; Rudolf J J Neurol Neurosurg Psychiatry; 2001 Aug; 71(2):193-9. PubMed ID: 11459891 [TBL] [Abstract][Full Text] [Related]
20. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study. Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]